Europe Melanoma Therapeutics Market Size & Outlook
Related Markets
Europe melanoma therapeutics market highlights
- The Europe melanoma therapeutics market generated a revenue of USD 1,658.8 million in 2024.
- The market is expected to grow at a CAGR of 9% from 2025 to 2030.
- In terms of segment, immunotherapies was the largest revenue generating product in 2024.
- Immunotherapies is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 1,658.8 million |
| Market revenue in 2030 | USD 2,777.3 million |
| Growth rate | 9% (CAGR from 2025 to 2030) |
| Largest segment | Immunotherapies |
| Fastest growing segment | Immunotherapies |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunotherapies, Targeted Therapies, Chemotherapies, Radiation therapy |
| Key market players worldwide | Bristol-Myers Squibb Co, AstraZeneca PLC, Novartis AG ADR, Merck & Co Inc, Amgen Inc, Abbott Laboratories, Roche Holding AG |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.4% of the global melanoma therapeutics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,775.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Melanoma Therapeutics Market Scope
Melanoma Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Europe melanoma therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to melanoma therapeutics market will help companies and investors design strategic landscapes.
Immunotherapies was the largest segment with a revenue share of 45.1% in 2024. Horizon Databook has segmented the Europe melanoma therapeutics market based on immunotherapies, targeted therapies, chemotherapies, radiation therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe melanoma therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe melanoma therapeutics market databook
-
Our clientele includes a mix of melanoma therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe melanoma therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe melanoma therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe melanoma therapeutics market size, by country, 2018-2030 (US$M)
Europe Melanoma Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
